Followers | 1398 |
Posts | 59304 |
Boards Moderated | 6 |
Alias Born | 11/08/2005 |
Thursday, December 20, 2012 8:09:56 AM
Recent FOLD News
- Amicus Therapeutics to Present at Upcoming Investor Conferences in November 2024 • GlobeNewswire Inc. • 11/01/2024 11:00:00 AM
- Amicus Therapeutics to Announce Third Quarter 2024 Financial Results on November 6, 2024 • GlobeNewswire Inc. • 10/28/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/17/2024 11:00:22 AM
- Amicus Therapeutics Announces Settlement of Galafold® (migalastat) Patent Litigation with Teva • GlobeNewswire Inc. • 10/17/2024 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/04/2024 08:05:42 PM
- Amicus Therapeutics Announces Participation at the World Muscle Society Annual Congress 2024 • GlobeNewswire Inc. • 10/04/2024 11:00:00 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 10/01/2024 08:35:02 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/05/2024 09:01:14 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/03/2024 08:19:15 PM
- UPDATE -- Amicus Therapeutics to Present at Upcoming Investor Conferences in September 2024 • GlobeNewswire Inc. • 09/03/2024 11:46:15 AM
- Amicus Therapeutics to Present at Upcoming Investor Conferences in September 2024 • GlobeNewswire Inc. • 09/03/2024 11:05:20 AM
- Amicus Therapeutics Announces Participation at the SSIEM 2024 Annual Symposium • GlobeNewswire Inc. • 09/03/2024 11:00:00 AM
- Amicus Therapeutics to Present at Upcoming Investor Conferences in September 2024 • GlobeNewswire Inc. • 08/30/2024 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/23/2024 09:10:30 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/08/2024 08:02:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2024 11:01:31 AM
- Amicus Therapeutics Announces Second Quarter 2024 Financial Results and Corporate Updates • GlobeNewswire Inc. • 08/08/2024 11:00:21 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/06/2024 12:10:03 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/01/2024 08:25:03 PM
- Amicus Therapeutics to Announce Second Quarter 2024 Financial Results on August 8, 2024 • GlobeNewswire Inc. • 07/30/2024 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/09/2024 09:01:29 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/07/2024 11:54:51 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/07/2024 11:53:32 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/07/2024 11:52:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/07/2024 11:49:26 PM
CBD Life Sciences Inc. (CBDL) Launches High-Demand Mushroom Gummy Line for Targeted Wellness Needs, Tapping into a Booming $20 Billion Market • CBDL • Oct 31, 2024 8:00 AM
Nerds On Site Announces Q1 Growth and New Initiatives for the Remainder of 2024 • NOSUF • Oct 31, 2024 7:01 AM
Innovation Beverage Group Receives Largest Shipment of its Top-Selling Bitters to Date in the U.S.-Ready to Meet Growing Demand from Expanding Distribution Network • IBG • Oct 30, 2024 12:22 PM
Element79 Gold Corp to Update Investors on the Emerging Growth Conference on October 31, 2024 • ELMGF • Oct 30, 2024 9:08 AM
CBD Life Sciences Inc. (CBDL) Announces Grand View Research Report Findings on High - Growth CBD Equine Market, Aiming to Drive Unprecedented Shareholder Value • CBDL • Oct 29, 2024 10:19 AM
Integrated Ventures Announces Partnership And Lease Agreement with Driptide Wellness - Leading Health and Wellness Provider. • INTV • Oct 29, 2024 8:45 AM